In patients with PTH-independent hypercalcaemia, the measurement of vitamin D metabolites using LC–MS/MS analytical technique, followed by genetic testing (e.g., NGS technique), may help to identify carriers of CYP24A1 mutations. This evidence concerns the gene CYP24A1 and Hypercalcemia.